Sutro Biopharma STRO
NASDAQ STRO
$11.54 +0.28 (+2.53%)
At close: Oct 20, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Preferred Stock Liabilities (2017 - 2018)

Updated

Sutro Biopharma's Preferred Stock Liabilities came in at $187.25 million for Q3 2018.

Analysis

Sutro Biopharma (STRO) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends

At the end of FY2017, Sutro Biopharma's Preferred Stock Liabilities was $102.51 million, unchanged from FY2016.

  • Going back by year, Preferred Stock Liabilities was $102.51 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Sutro Biopharma 190.66 Mn -487.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 187.25 Mn
Dec 31, 2017 102.51 Mn
API Access

Sutro Biopharma Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=STRO&period=max&api_key=YOUR_API_KEY